Harding Loevner LP Johnson & Johnson Transaction History

Harding Loevner LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $11,293 - $12,566	70 New	70 $11,000
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $79,228 - $89,974	-501 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $41,973 - $45,995	-299 Reduced 37.38%	501 $75,000
Q4 2017 Feb 12, 2018	SELL	$131.22 - $143.62 $54,325 - $59,458	-414 Reduced 34.1%	800 $112,000
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $157,176 - $164,351	1,214	1,214 $158,000

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Harding Loevner LP, based on Form 13F filings with the SEC.

Stay updated on Harding Loevner LP with notifications on news.